Cutting Edge: Hypoxia Sensing by the Histone Demethylase UTX (KDM6A) Limits Colitogenic CD4+ T Cells in Mucosal Inflammation
The Journal of Immunology · 01.04.2024 · 212 (7) · 1069-1074
DOI: 10.4049/jimmunol.2300550 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 14.02.2024. Verfasst von Mandy I Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Hypoxia is a hallmark of inflammatory conditions (e.g., inflammatory bowel disease [IBD]), and adaptive responses have consequently evolved to protect against hypoxia-associated tissue injury. Because augmenting hypoxia-induced protective responses is a promising therapeutic approach for IBD, a more complete understanding of these pathways is needed. Recent work has demonstrated that the histone demethylase UTX is oxygen-sensitive, but its role in IBD is unclear. In this study, we show that hypoxia-induced deactivation of UTX downregulates T cell responses in mucosal inflammation. Hypoxia results in decreased T cell proinflammatory cytokine production and increased immunosuppressive regulatory T cells, and these findings are recapitulated by UTX deficiency. Hypoxia leads to T cell accumulation of H3K27me3 histone modifications, suggesting that hypoxia impairs UTX’s histone demethylase activity to dampen T cell colitogenic activity. Finally, T cell–specific UTX deletion ameliorates colonic inflammation in an IBD mouse model, implicating UTX’s oxygen-sensitive demethylase activity in counteracting hypoxic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA.
- Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA.
- Division of Hematology and Oncology at Translational Science Research Institute, Scripps Research, La Jolla, CA.
- Center for Gastrointestinal Biology and Disease, UNC Chapel Hill, NC.
- Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
ORCID-Profile: Mandy I Cheng, Lee Hong, Christian Bustillos, Bryan Chen, Scott Chin, Christopher R Luthers, Maureen A Su
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- NINDS NIH HHS
- HHS | NIH | National Institute of Neurological Disorders and Stroke
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Cheng, M. I., Hong, L., Bustillos, C., Chen, B., Chin, S., Luthers, C. R., Vo, A., Sheikh, S. Z., & Su, M. A. (2024). Cutting Edge: Hypoxia Sensing by the Histone Demethylase UTX (KDM6A) Limits Colitogenic CD4+ T Cells in Mucosal Inflammation. The Journal of Immunology, 212(7), 1069-1074. https://doi.org/10.4049/jimmunol.2300550
Vancouver
Cheng MI, Hong L, Bustillos C, Chen B, Chin S, Luthers CR, et al. Cutting Edge: Hypoxia Sensing by the Histone Demethylase UTX (KDM6A) Limits Colitogenic CD4+ T Cells in Mucosal Inflammation. The Journal of Immunology. 2024;212(7):1069-1074. doi:10.4049/jimmunol.2300550
BibTeX
@article{Cheng2024,
author = {Cheng, Mandy I and Hong, Lee and Bustillos, Christian and Chen, Bryan and Chin, Scott and Luthers, Christopher R and Vo, Au and Sheikh, Shehzad Z and Su, Maureen A},
title = {Cutting Edge: Hypoxia Sensing by the Histone Demethylase UTX (KDM6A) Limits Colitogenic CD4+ T Cells in Mucosal Inflammation},
journal = {The Journal of Immunology},
year = {2024},
volume = {212},
number = {7},
pages = {1069--1074},
doi = {10.4049/jimmunol.2300550}
}
EUVIMED